Icosagen as Technology & Service Provider

Icosagen as Technology & Service Provider

Products

Information

- Mammalian protein drug candidate CRDMO - Uniquely combining pre-clinical CRO and clinical CDMO capabilities - 230+ people, >200 scientists (>45 PhD’s) all in one single site - Founded 1999, fully independent, successful 26-yr family-business - Integrated, modular CRDMO services, from discovery to 1000L GMP-scale manufacturing - Worked for >100 biotechs / pharma firms in 2024, on >400 projects, producing >2000 proteins - ISO 9001:2015 certified - Professional PhD-level project managers, problem-solving skills, detailed reports - Own anti-COVID nasal spray on the market, with anti-spike protein mAbs - 93% client satisfaction and repeat business - Based in Tartu, Estonia, Europe
IcosagenIcosagen is a private, independent family-business, advancing therapeutic proteins from mammalian cells since 26 years. As CRDMO, we uniquely combine pre-clinical CRO and clinical CDMO capabilities at one site, advancing molecules from discovery through R&D stages, into stable IcoCell(R) CHO cell lines and GMP manufacturing. From mAbs, complex multi-specifics to ADCs or recombinant proteins, we accelerate the programs of over 100 biotechs annually, eliminating error-prone tech transfers to save our partners' time, cost and effort.

Log in

See all the content and easy-to-use features by logging in or registering!